Design Therapeutics's total assets for Q4 2025 were $226.20M, an increase of 6.82% from the previous quarter. DSGN total liabilities were $13.70M for the fiscal quarter, a 13.69% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.